Suppr超能文献

治疗炎症性痛觉过敏的新策略。

Novel strategies for the treatment of inflammatory hyperalgesia.

机构信息

Department of Pharmacology, Rajarambapu College of Pharmacy, Kasegaon, Taluka: Walwa, Sangli, 415404, Maharashtra, India.

出版信息

Eur J Clin Pharmacol. 2010 May;66(5):429-44. doi: 10.1007/s00228-010-0784-7. Epub 2010 Feb 13.

Abstract

There is a large unmet medical need in the area of treatment of inflammatory pain initiated by tissue damage or inflammation that manifests as spontaneous pain and pain hypersensitivity (hyperalgesia).The current review focuses on the key mechanisms that produce hyperalgesia that accompanies inflammation. Also, the inflammatory mediators that interact with neurons to produce hyperalgesia are explored. As the dominant classes of analgesic drugs such as the NSAIDs and the opiates are limited by their side effects and tolerability, elucidation of the molecular mechanisms responsible for inflammatory pain provides novel opportunities for therapeutic approaches for managing inflammatory pain, with improved specificity, efficacy, and possibly with fewer toxic effects.

摘要

在治疗由组织损伤或炎症引起的炎症性疼痛方面存在着巨大的未满足的医疗需求,这种疼痛表现为自发性疼痛和痛觉过敏(痛觉超敏)。本综述重点介绍了产生伴随炎症的痛觉过敏的关键机制。此外,还探讨了与神经元相互作用产生痛觉过敏的炎症介质。由于非甾体抗炎药和阿片类药物等主要类别的镇痛药受到其副作用和耐受性的限制,阐明导致炎症性疼痛的分子机制为管理炎症性疼痛提供了新的治疗方法的机会,这些方法具有更好的特异性、疗效,并且可能毒性更小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验